You have to be nuts to have someone inches away from your face for a Botox injection right now, but I have no doubt plenty will go for it especially younger millennials. The delay in the RVNC BLA filing pushing off launch to next year may not make much difference when all is is said and done bc this year is a disaster. I still stand by comments I made that the ability to spread out doctors visits is that much more of an advantage for the company post covid. It may be the only discretionary type stock I end up holding (the therapeutics side to the business provides the more traditional less discretionary type model of course)
Market Data 
Markets 
AI
